Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

BACKGROUND: Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection is associated with hypercoagulability caused by direct invasion of endothelial cells and\or proinflammatory cytokine release. Thromboprophylaxis with enoxaparin is recommended by current guidelines, but evidence is st...

Descripción completa

Detalles Bibliográficos
Autores principales: Albani, Filippo, Sepe, Lilia, Fusina, Federica, Prezioso, Chiara, Baronio, Manuela, Caminiti, Federica, Di Maio, Antonella, Faggian, Barbara, Franceschetti, Maria Elena, Massari, Marco, Salvaggio, Marcello, Natalini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://www.ncbi.nlm.nih.gov/pubmed/33043287
http://dx.doi.org/10.1016/j.eclinm.2020.100562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534836/
https://www.ncbi.nlm.nih.gov/pubmed/33043287
http://dx.doi.org/10.1016/j.eclinm.2020.100562

Ejemplares similares